Association of fatigue and depression with circulating levels of proinflammatory cytokines and epidermal growth factor receptor ligands: a correlative study of a placebo-controlled fatigue trial

References

• BarsevickAFrostMZwindermanAHallPHalyardMI’m so tired: biological and genetic mechanisms of cancer-related fatigueQual Life Res201019101419142720953908
   PubMed Web of Science ®Google Scholar
• HartBLBiological basis of the behavior of sick animalsNeurosci Biobehav Rev19881221231373050629
   PubMed Web of Science ®Google Scholar
• CleelandCSBennettGJDantzerRAre the symptoms of cancer and cancer treatment due to a shared biologic mechanism?Cancer200397112919292512767108
   PubMed Web of Science ®Google Scholar
• BowerJEGanzPAAzizNFaheyJLFatigue and proinflammatory cytokine activity in breast cancer survivorsPsychosom Med200264460461112140350
   PubMed Web of Science ®Google Scholar
• MyersJSProinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptomsOncol Nurs Forum200835580280718765326
   PubMed Web of Science ®Google Scholar
• MusselmanDLMillerAHPorterMRHigher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findingsAm J Psychiatry200115881252125711481159
   PubMed Web of Science ®Google Scholar
• RichTInnominatoPFBoernerJElevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancerClin Cancer Res20051151757176415755997
   PubMed Web of Science ®Google Scholar
• KurzrockRThe role of cytokines in cancer-related fatigueCancer200192Suppl 61684168811598887
   PubMed Web of Science ®Google Scholar
• GreenbergDGGrayJLMannixCMEisenthaISCareyMTreatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancerJ Pain Symptom Manage1993841962007963760
   PubMed Web of Science ®Google Scholar
• CapuronLRavaudADantzerREarly depressive symptoms in cancer patients receiving interleukin-2 and/or interferon alfa-2b therapyJ Clin Oncol200018102143215110811680
   PubMed Web of Science ®Google Scholar
• DantzerRO’ConnorJCFreundGGJohnsonRWKelleyKWFrom inflammation to sickness and depression: when the immune system subjugates the brainNat Rev Neurosci200891465618073775
   PubMed Web of Science ®Google Scholar
• KramerAYangFCSnodgrassPLiXScammellTEDavisFCWeitzCJRegulation of daily locomotor activity and sleep by hypothalamic EGF receptor signalingScience200129455512511251511752569
   PubMed Web of Science ®Google Scholar
• RichTASymptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axisJ Support Oncol200754167174 discussion 76–7717500504
   PubMedGoogle Scholar
• Snodgrass-BeltPGilbertJLDavisFCCentral administration of transforming growth factor-alpha and neuregulin-1 suppress active behaviors and cause weight loss in hamstersBrain Res20051038217118215757633
   PubMed Web of Science ®Google Scholar
• GilbertJDavisFCBehavioral effects of systemic transforming growth factor-alpha in Syrian hamstersBehav Brain Res2009198244044819110003
   PubMed Web of Science ®Google Scholar
• CrucianiRAZhangJJManolaJCellaDAnsariBFischMJL-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trialJ Clin Oncol201230313864386922987089
   PubMed Web of Science ®Google Scholar
• MendozaTRWangXSCleelandCSMorrisseyMJohnsonBAWendtJKHuberSLThe rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue InventoryCancer19998551186119610091805
   PubMed Web of Science ®Google Scholar
• RadloffLCES-D Scale: a self-report depression scale for research in the general populationAppl Psychol Measur19771385401
   Web of Science ®Google Scholar
• HannDWinterKJacobsenPMeasurement of depressive symptoms in cancer patients. evaluation of the Center for Epidemiological Studies Depression Scale (CES-D)J Psychosom Res199946543744310404478
   PubMed Web of Science ®Google Scholar
• MiaskowskiCDoddMWestCPaulSMSchumacherKTripathyDKooPThe use of a responder analysis to identify differences in patient outcomes following a self-care intervention to improve cancer pain managementPain20071291–2556317257753
   PubMed Web of Science ®Google Scholar
• KleinerGMarcuzziAZaninVMonastaLZauliGCytokine levels in the serum of healthy subjectsMediators Inflamm2013201316
   Web of Science ®Google Scholar
• KimHOKimHSYounJCShinECParkSSerum cytokine profiles in healthy young and elderly population assessed using multiplexed bead-based immunoassaysJ Transl Med2011911321774806
   PubMed Web of Science ®Google Scholar
• BowerJEGanzPATaoMLInflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancerClin Cancer Res200915175534554019706826
   PubMed Web of Science ®Google Scholar
• SchubertCHongSNatarajanLMillsPJDimsdaleJEThe association between fatigue and inflammatory marker levels in cancer patients: a quantitative reviewBrain Behav Immun200721441342717178209
   PubMed Web of Science ®Google Scholar
• JehnCFKuehnhardtDBartholomaeABiomarkers of depression in cancer patientsCancer2006107112723272917036362
   PubMed Web of Science ®Google Scholar
• BarsevickACellaDNCI Symptom Management and Quality of Life Steering Committee Clinical Trials Planning Conference: Cancer-Related FatigueBethesda, MDNational Institutes of Health2010
   Google Scholar
• YennurajalingamSFrisbee-HumeSPalmerJLReduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancerJ Clin Oncol201331253076308223897970
   PubMed Web of Science ®Google Scholar
• BaylissTJSmithJTSchusterMDragnevKHRigasJRA humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancerExpert Opin Biol Ther201111121663166821995322
   PubMed Web of Science ®Google Scholar
• CellaDHerbstRSLynchTJClinically meaningful improvement in symptoms and quality of life for patients with non-small-cell lung cancer receiving gefitinib in a randomized controlled trialJ Clin Oncol200523132946295415699477
   PubMed Web of Science ®Google Scholar
• IurisciIRichTLeviFRelief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancerJ Clin Oncol20072516e17e1917538154
   PubMed Web of Science ®Google Scholar
• SpathisASFifeKBlackhallFModafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trialJ Clinl Oncol2014321818821888
   PubMed Web of Science ®Google Scholar
• BenedettiFAmanzioMMechanisms of the placebo responsePulm Pharmacol Ther201326552052323370213
   PubMed Web of Science ®Google Scholar
• FinnissDGKaptchukTJMillerFBenedettiFBiological, clinical, and ethical advances of placebo effectsLancet2010375971568669520171404
   PubMed Web of Science ®Google Scholar